Involvement of 5-HT1A receptors in homeostatic and stress-induced adaptive regulations of paradoxical sleep:: Studies in 5-HT1A knock-out mice

被引:115
作者
Boutrel, B
Monaca, C
Hen, R
Hamon, M
Adrien, J
机构
[1] Univ Paris 06, INSERM, U288, F-75634 Paris 13, France
[2] Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA
关键词
sleep-wakefulness; 5-HT1A receptors; sleep deprivation; immobilization stress; knock-out mice; paradoxical sleep homeostasis;
D O I
10.1523/JNEUROSCI.22-11-04686.2002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
For the last two decades, the involvement of 5-HT1A receptors in the regulation of vigilance states has been studied extensively thanks to pharmacological tools, but clear-cut conclusion has not been reached yet. By studying mutant mice that do not express this receptor type (5-HT1A-/-) and their wild-type 129/Sv counterparts, we herein demonstrate that 5-HT1A receptors play key roles in the control of spontaneous sleep-wakefulness cycles, as well as in homeostatic regulation and stress-induced adaptive changes of paradoxical sleep. Both strains of mice exhibited a diurnal sleep-wakefulness rhythm, but 5-HT1A-/- animals expressed higher amounts of paradoxical sleep than wild-type mice during both the light and the dark phases. In wild-type mice, pharmacological blockade of 5-HT1A receptors by WAY 100635 (0.5 mg/kg, i.p.) promoted paradoxical sleep, whereas the 5-HT1A agonist 8-OH-DPAT (0.25-1 mg/kg, s.c.) had an opposite effect. In contrast, none of the 5-HT1A receptor ligands affected sleep significantly in 5-HT1A-/- mice. However, 5-HT1B receptor stimulation by CP 94253 (1-3 mg/kg, i.p.) induced a reduction in paradoxical sleep in both strains, this effect being more pronounced in 5-HT1A-/- mutants. Finally, in contrast to wild-type mice, 5-HT1A-/- mutants did not exhibit any rebound of paradoxical sleep after either a 9 hr instrumental paradoxical sleep deprivation or a 90 min immobilization stress. Altogether, these data indicate that, in the mouse, 5-HT1A receptors participate in the spontaneous and homeostatic regulation, as well as in stress-induced adaptive changes of paradoxical sleep.
引用
收藏
页码:4686 / 4692
页数:7
相关论文
共 52 条
  • [1] PRESENCE OF A PARADOXICAL SLEEP (PS) FACTOR IN THE CEREBROSPINAL-FLUID OF PS-DEPRIVED RATS
    ADRIEN, J
    DUGOVIC, C
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 100 (02) : 223 - 226
  • [2] Homeostatic regulation of REM sleep in humans during extended sleep
    Barbato, G
    Wehr, TA
    [J]. SLEEP, 1998, 21 (03) : 267 - 276
  • [3] Sleep/waking effects of a selective 5-HT1A receptor agonist given systemically as well as perfused in the dorsal raphe nucleus in rats
    Bjorvatn, B
    Fagerland, S
    Eid, T
    Ursin, R
    [J]. BRAIN RESEARCH, 1997, 770 (1-2) : 81 - 88
  • [4] Boutrel B, 1999, J NEUROSCI, V19, P3204
  • [5] Corticosterone responses in 5-HT1B receptor knockout mice to stress or 5-HT1A receptor activation are normal
    Bouwknecht, JA
    van der Gugten, J
    Hijzen, TH
    Maes, RAA
    Hen, R
    Olivier, B
    [J]. PSYCHOPHARMACOLOGY, 2001, 153 (04) : 484 - 490
  • [6] Effects of adrenalectomy and subsequent corticosterone replacement on rat sleep state and EEG power spectra
    Bradbury, MJ
    Dement, WC
    Edgar, DM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1998, 275 (02) : R555 - R565
  • [7] EVIDENCE FOR A SLEEP-PROMOTING INFLUENCE OF STRESS
    CESPUGLIO, R
    MARINESCO, S
    BAUBET, V
    BONNET, C
    ELKAFI, B
    [J]. ADVANCES IN NEUROIMMUNOLOGY, 1995, 5 (02): : 145 - 154
  • [8] Serotonin type-1A receptor imaging in depression
    Drevets, WC
    Frank, E
    Price, JC
    Kupfer, DJ
    Greer, PJ
    Mathis, C
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2000, 27 (05) : 499 - 507
  • [9] THE INFLUENCE OF IPSAPIRONE, A 5-HT1A AGONIST, ON SLEEP PATTERNS OF HEALTHY-SUBJECTS
    DRIVER, HS
    FLANIGAN, MJ
    BENTLEY, AJ
    LUUS, HG
    SHAPIRO, CM
    MITCHELL, D
    [J]. PSYCHOPHARMACOLOGY, 1995, 117 (02) : 186 - 192
  • [10] 5-HT1-LIKE RECEPTOR AGONISTS ENHANCE WAKEFULNESS
    DZOLJIC, MR
    UKPONMWAN, OE
    SAXENA, PR
    [J]. NEUROPHARMACOLOGY, 1992, 31 (07) : 623 - 633